Citation Impact
Citing Papers
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside?
2011
Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management
2015
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Fibroblast activation and myofibroblast generation in obstructive nephropathy
2009
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
TGF-β: the master regulator of fibrosis
2016 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis
2008
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Effector Mechanisms of Rejection
2013
Therapeutic Apheresis for Renal Disorders
2012
Fibrosis and evidence for epithelial‐mesenchymal transition in the kidneys of patients with staghorn calculi
2011
Mechanisms of Tubulointerstitial Fibrosis
2010
Summary of FDA Antibody-Mediated Rejection Workshop
2011
New Insights into the Regulation of Epithelial–Mesenchymal Transition and Tissue Fibrosis
2012
Acute kidney injury
2021 Standout
Plasma Exchange for Kidney Disease: What Is the Best Evidence?
2014
EMT: 2016
2016 Standout
B Cells, Antibodies, and More
2015
Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor-Specific Antibodies (DSA)
2010
Scar wars: mapping the fate of epithelial–mesenchymal–myofibroblast transition
2011
Prevention and treatment of alloantibody-mediated kidney transplant rejection
2011
New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
2009
Renal fibrosis: novel insights into mechanisms and therapeutic targets
2010
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
2011 Standout
Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study
2010
Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?
2020
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Therapeutic apheresis in kidney transplantation: A review of renal transplant immunobiology and current interventions with apheresis medicine
2013
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Treatment of antibody‐mediated rejection in renal transplant patients: a clinical practice survey
2014
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
2012 Standout
Resolved
2010
Mechanisms of Renal Fibrosis
2017 Standout
Antibody‐Mediated Rejection in Kidney Transplantation: A Review of Pathophysiology, Diagnosis, and Treatment Options
2014
Works of J. Vérine being referenced
Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: case report
2011
Comparison of Combination Plasmapheresis/IVIg/ Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection
2009
Risk Factors for Early Epithelial to Mesenchymal Transition in Renal Grafts
2006
Human De Novo Papillary Renal-Cell Carcinomas in a Kidney Graft: Evidence of Recipient Origin With Adenoma-Carcinoma Sequence
2013
Early Epithelial Phenotypic Changes Predict Graft Fibrosis
2008